Area of research
Oncology · Pharmacology
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Drug Solubulity and Delivery Systems, Lung Cancer Treatments and Mutations, and Lung Cancer Research Studies.
Faecal metabolites as a readout of habitual diet capture dietary interactions with the gut microbiome
Developing and Evaluating Large Language Model–Generated Emergency Medicine Handoff Notes
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathway
Systemic immune‐inflammation index is associated with ulcerative plaque in patients with acute ischemic stroke: A single center exploratory study
SYST-16 ANXA5 PROMOTES GLIOMA PROGRESSION THROUGH THE FAK/PI3K/AKT PATHWAY
Clinical Implications of Altered Drug Transporter Abundance/Function and <scp>PBPK</scp> Modeling in Specific Populations: An <scp>ITC</scp> Perspective
Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2
Circulating Levels of the Short-Chain Fatty Acid Acetate Mediate the Effect of the Gut Microbiome on Visceral Fat
Detection of cancer specific mutations in early-stage non-small cell lung cancer using cell-free DNA by targeted sequencing
Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop